BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies

Hisashi Sawada; Alan Daugherty

doi:10.1161/CIRCULATIONAHA.123.065946

BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	607-609
Number of pages	3
Journal	Circulation
Volume	148
Issue number	7
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.123.065946
State	Published - Aug 15 2023

Bibliographical note

Funding Information:
The authors’ research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL155649) and the American Heart Association Merit Award (23MERIT1036341). The content in this editorial is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Keywords

Editorials
aneurysm
angiotensins
aorta
dissection
myocytes, smooth muscle
vascular diseases

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.123.065946

Cite this

@article{146668980f2740e18be415ea537c50ec,

title = "BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies",

keywords = "Editorials, aneurysm, angiotensins, aorta, dissection, myocytes, smooth muscle, vascular diseases",

author = "Hisashi Sawada and Alan Daugherty",

note = "Funding Information: The authors{\textquoteright} research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL155649) and the American Heart Association Merit Award (23MERIT1036341). The content in this editorial is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ",

year = "2023",

month = aug,

day = "15",

doi = "10.1161/CIRCULATIONAHA.123.065946",

language = "English",

volume = "148",

pages = "607--609",

number = "7",

}

TY - JOUR

T1 - BEST3-Mediated MEKK2/3 Activation

T2 - A Novel Therapeutic Target in Aortopathies

AU - Sawada, Hisashi

AU - Daugherty, Alan

N1 - Funding Information: The authors’ research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R35HL155649) and the American Heart Association Merit Award (23MERIT1036341). The content in this editorial is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2023/8/15

Y1 - 2023/8/15

KW - Editorials

KW - aneurysm

KW - angiotensins

KW - aorta

KW - dissection

KW - myocytes, smooth muscle

KW - vascular diseases

UR - http://www.scopus.com/inward/record.url?scp=85168189302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85168189302&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.123.065946

DO - 10.1161/CIRCULATIONAHA.123.065946

M3 - Editorial

C2 - 37579014

AN - SCOPUS:85168189302

SN - 0009-7322

VL - 148

SP - 607

EP - 609

JO - Circulation

JF - Circulation

IS - 7

ER -

BEST3-Mediated MEKK2/3 Activation: A Novel Therapeutic Target in Aortopathies

Bibliographical note

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this